Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | lysine (K)-specific demethylase 4A | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | 3-oxoacyl-[acyl-carrier-protein] synthase III FabH (beta-ketoacyl-ACP synthase III) (KAS III) | 0.5639 | 1 | 1 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0732 | 0.1205 | 1 |
Brugia malayi | prolyl oligopeptidase family protein | 0.0341 | 0.0504 | 0.0592 |
Brugia malayi | prolyl oligopeptidase family protein | 0.1628 | 0.2811 | 0.3961 |
Echinococcus granulosus | prolyl endopeptidase | 0.0341 | 0.0504 | 0.0592 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.5639 | 1 | 1 |
Trypanosoma cruzi | serine peptidase, Clan SC, Family S9B | 0.1628 | 0.2811 | 1 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0732 | 0.1205 | 1 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0732 | 0.1205 | 1 |
Loa Loa (eye worm) | prolyl oligopeptidase | 0.3935 | 0.6946 | 1 |
Echinococcus multilocularis | Dipeptidyl peptidase 9 | 0.1628 | 0.2811 | 0.3961 |
Brugia malayi | prolyl oligopeptidase family protein | 0.3935 | 0.6946 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0522 | 0.0827 | 0.119 |
Toxoplasma gondii | dipeptidyl peptidase iv (dpp iv) n-terminal region domain-containing protein | 0.1448 | 0.2488 | 1 |
Schistosoma mansoni | dipeptidyl-peptidase 9 (S09 family) | 0.1628 | 0.2811 | 0.3998 |
Plasmodium falciparum | beta-ketoacyl-ACP synthase III | 0.5639 | 1 | 1 |
Schistosoma mansoni | acylaminoacyl-peptidase (S09 family) | 0.0341 | 0.0504 | 0.065 |
Mycobacterium leprae | PROBABLE PROTEASE II PTRBB (OLIGOPEPTIDASE B) | 0.0341 | 0.0504 | 0.5 |
Giardia lamblia | Alanyl dipeptidyl peptidase | 0.0341 | 0.0504 | 0.5 |
Trichomonas vaginalis | Clan SC, family S9, acylaminoacyl-peptidase-like serine peptidase | 0.0341 | 0.0504 | 0.5 |
Brugia malayi | prolyl oligopeptidase family protein | 0.0341 | 0.0504 | 0.0592 |
Echinococcus multilocularis | acylamino acid releasing enzyme | 0.0341 | 0.0504 | 0.0592 |
Trypanosoma cruzi | dipeptidyl-peptidase 8-like serine peptidase | 0.1628 | 0.2811 | 1 |
Schistosoma mansoni | prolyl oligopeptidase (S09 family) | 0.0341 | 0.0504 | 0.065 |
Giardia lamblia | Alanyl dipeptidyl peptidase | 0.0341 | 0.0504 | 0.5 |
Plasmodium vivax | beta-ketoacyl-acyl carrier protein synthase III precursor, putative | 0.5639 | 1 | 1 |
Schistosoma mansoni | prolyl oligopeptidase (S09 family) | 0.0341 | 0.0504 | 0.065 |
Loa Loa (eye worm) | hypothetical protein | 0.0341 | 0.0504 | 0.0725 |
Loa Loa (eye worm) | prolyl oligopeptidase | 0.0341 | 0.0504 | 0.0725 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0341 | 0.0504 | 0.5 |
Echinococcus granulosus | Dipeptidyl peptidase 9 | 0.1628 | 0.2811 | 0.3961 |
Trypanosoma brucei | serine peptidase, Clan SC, Family S9B | 0.1628 | 0.2811 | 1 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0341 | 0.0504 | 0.5 |
Onchocerca volvulus | Dipeptidyl peptidase family member 1 homolog | 0.3935 | 0.6946 | 1 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0732 | 0.1205 | 1 |
Echinococcus granulosus | acylamino acid releasing enzyme | 0.0341 | 0.0504 | 0.0592 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.5639 | 1 | 1 |
Echinococcus multilocularis | dipeptidyl aminopeptidaseprotein | 0.3935 | 0.6946 | 1 |
Leishmania major | dipeptidyl-peptidase 8-like serine peptidase, putative,serine peptidase, Clan SC, Family S9B | 0.1628 | 0.2811 | 1 |
Echinococcus multilocularis | prolyl endopeptidase | 0.0341 | 0.0504 | 0.0592 |
Brugia malayi | hypothetical protein | 0.1107 | 0.1876 | 0.2596 |
Wolbachia endosymbiont of Brugia malayi | 3-oxoacyl-ACP synthase | 0.5639 | 1 | 0.5 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0073 | 0.0022 | 0.0032 |
Schistosoma mansoni | subfamily S9B unassigned peptidase (S09 family) | 0.3935 | 0.6946 | 1 |
Mycobacterium ulcerans | beta-ketoacyl synthase-like protein | 0.5639 | 1 | 1 |
Schistosoma mansoni | prolyl oligopeptidase (S09 family) | 0.0341 | 0.0504 | 0.065 |
Loa Loa (eye worm) | hypothetical protein | 0.0341 | 0.0504 | 0.0725 |
Echinococcus granulosus | dipeptidyl aminopeptidaseprotein | 0.3935 | 0.6946 | 1 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0732 | 0.1205 | 1 |
Trypanosoma brucei | Dipeptidyl-peptidase 8-like, putative | 0.1628 | 0.2811 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.1107 | 0.1876 | 0.2701 |
Brugia malayi | prolyl oligopeptidase family protein | 0.0341 | 0.0504 | 0.0592 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 1.7783 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Vif-A3F Interactions: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 44.6684 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Potency (functional) | 44.6684 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 100 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.